A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
about
Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.Cyanidin-3-O-β-glucoside combined with its metabolite protocatechuic acid attenuated the activation of mice hepatic stellate cells.The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence.Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.Proposed mechanisms of the effects of proanthocyanidins on glucose homeostasis.Effects of Anthocyanins on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes.The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases.Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses.Effect of Anthocyanin Supplementations on Lipid Profile and Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
P2860
Q38599131-811AA498-AED4-49AA-8015-FE84A250ADD0Q38660727-D8ADCA4A-A492-4F0A-9167-01D01E2A8876Q38725130-90B050A1-BB12-4DD8-9B3E-5280DF30A734Q41528687-632EB90D-2463-4F2E-B989-F7666BAEFA4AQ45801443-57CE9B9C-F1BF-4A74-AE7E-962329A5FB37Q47713949-FB451B47-B578-4C17-A6EB-B8020C8D0972Q48337235-B57812B7-163B-4174-BCEC-53E899BDDD0AQ51264836-FA219FB3-84A6-4492-9C4A-678A92BDC989Q52672982-66B4C8A2-68F5-4841-8992-534A183C9270Q52803217-239535CA-33EA-4A3E-8F5B-B693980CFE95Q54996429-BA0577DF-E679-4DD6-A03B-374F200CE9F0
P2860
A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@ast
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@en
type
label
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@ast
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@en
prefLabel
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@ast
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@en
P2093
P2860
P1433
P1476
A CONSORT-compliant, randomize ...... alcoholic fatty liver disease.
@en
P2093
Feng-Xia Chen
Hong-Hui Guo
Pei-Wen Zhang
Wen-Hua Ling
P2860
P356
10.1097/MD.0000000000000758
P407
P577
2015-05-01T00:00:00Z